Bronchodilator reversibility and cardiac considerations with use of tiotropium.
University of Groningen, Department of Pulmonary Medicine and Tuberculosis, and Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, 9700 RB Groningen, Netherlands. Electronic address: h.a.m.kerstjens@umcg.nl.
Huib A M
HA
Kerstjens
TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany.
Petra
P
Moroni-Zentgraf
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D000068299:Salmeterol Xinafoate / Q000627:therapeutic use*; D000069447:Tiotropium Bromide / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000069447:Tiotropium Bromide